Study population and its coverage. by Chandra Kumar Dolla (5278010)

Subjects:

Risk-taking behavior identified by the BART decreases after acclimatization. by Erica C. Heinrich (6832055)

Correlation coefficients and associated level of significance. by Ștefan Andrei Neştian (14755581)

Correlation coefficients and associated level of significance. by Ștefan Andrei Neştian (14755581)

The trend of patient characteristics, risk factors, and risk scores. by Ayako Shoji (78037)

Risks of bias of the included studies. by Siyuan Liu (696701)

Subjects:

<i>V. cholerae</i> exposure substantially remodels gene expression. by Longjun Pu (20685717)

Field name and reference level mapping. by Kara Keun Lee (14670497)

Characteristics of patients who had STI tests, American Family Cohort, 2019-2021. by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia (left) and gonorrhea (right) tests in the American Family Cohort in 2019, 2020, and 2021, age standardized to the U.S. st... by Shiying Hao (659634)

Subjects:

Quarterly test positivity for chlamydia (left) and gonorrhea (right) in the American Family Cohort from 2019 to 2021. by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by gender, age standardized to the U.S. sta... by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021, age standardized to the U.S. standard popu... by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients and the 95% confidence intervals (CIs) for the chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021. by Shiying Hao (659634)

Subjects:

Monthly number of tests per 100,000 patients for chlamydia, gonorrhea, syphilis, and HIV in the American Family Cohort from 2019 to 2021 by race/ethnicity, age standardized to the... by Shiying Hao (659634)

Subjects:

QUIPS risk of bias assessment. by Nabeela Arbee-Kalidas (17598969)

“…Higher estimates of peak, measured and as a percentagege of predicted, showed significant associations with a lower risk of mortality [MD: 3.66, 95% CI: 0.88; 6.43 and MD: 16.49, 95% CI: 6.92; 26.07] and fewer complications [MD: 2.06, 95% CI: 1.12; 3.00 and MD: 9.82, 95% CI: 5.88; 13.76]. …”

The trend of risk scores. by Ayako Shoji (78037)

Heat map of <i>S</i>. <i>carpocapsae</i> statistically significant proteins. by Peter E. Lillis (12368582)

GLS inhibition decreases IL-1β secretion <i>in vitro</i>. by Bárbara Ponzilacqua-Silva (17002156)

Cumulative proportion of positive urine samples and numbers at risk in active rTMS and sham-treated group with time (days). by Francesco Lolli (2530471)

Subjects: